熱門資訊> 正文
Altimmune定价2.25亿美元公开发行证券
2026-04-23 12:02
- Altimmune (ALT) priced an oversubscribed public offering of common stock, pre-funded warrants and accompanying common stock warrants to raise approximately $225 million in gross proceeds, according to a statement late on Wednesday.
- Offering includes 64.25M shares of common stock and pre-funded warrants to purchase an aggregate of up to 10.75M shares of common stock.
- Each security comes with accompanying common stock warrants at exercise price of $3.00 per share. Leerink Partners and Barclays are acting as joint bookrunning managers.
More on Altimmune
- Altimmune: Why I'm Downgrading To Hold Despite MASH Promise
- Altimmune: Considering If A Repeat Of The 2025 Run-Up Is On Tap
- Altimmune: The High Cost Of Going Solo (Rating Downgrade)
- Altimmune launches proposed public offering to fund late-stage trial
- Altimmune a new buy at Truist on pemvidutide promise
推薦文章
騰訊、阿里等中概巨頭業績來襲！AI收入轉化率成核心看點，這輪財報季能否助力恆科「反彈」？
港股周報 | 存儲芯片持續飆升！兩倍做多海力士周內狂漲64%；段永平重大調倉！清倉中國神華，大幅買入泡泡瑪特
一周財經日曆 | 下周重磅大事齊襲！特朗普政府或攜黃仁勛訪華；中概科網股財報季打響！騰訊、阿里同日放榜
美股機會日報 | 「TACO」已經過時？華爾街瘋狂湧入「NACHO」交易；今晚20:30！美國4月非農或創年內最大落差？
華盛早報 | 美伊突發交火！特朗普密集發聲施壓；英偉達官宣入股，IREN盤后一度暴漲27%
5月8日外盤頭條：美國計劃本周重啟護航行動 特朗普給予歐盟至7月4日批准貿易協議 OpenAI與博通芯片豪賭遇冷
CoreWeave一季度末簽約總電力容量3.5吉瓦 年內股價漲近80%
馬斯克再下注：SpaceX IPO倒計時 擬投1190億美元建Terafab芯片廠
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
